The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer

Cancer Research UK, Prostate Cancer Statistics, http://www.cancerresearchuk.org/healthprofessional/prostate-cancer-statistics [Accessed: April 2019]. Peschel, 2003, Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer, Lancet Oncol, 4, 10.1016/S1470-2045(03)01035-0 Garnick, 1993, Prostate cancer: screening, diagnosis, and management, Ann Intern Med, 118, 804, 10.7326/0003-4819-118-10-199305150-00008 Henson, 2011, Late onset bowel dysfunction after pelvic radiotherapy: a National survey of current practice and opinions of clinical oncologists, Clin Oncol, 23, 552, 10.1016/j.clon.2011.04.002 Dishe, 1989, The recording of morbidity related to radiotherapy, Radiother Oncol, 16, 103, 10.1016/0167-8140(89)90026-1 Bentzen, 2003, Normal tissue effects: reporting and analysis, Sem Radiat Oncol, 13, 189, 10.1016/S1053-4296(03)00036-5 Trotti, 2004, The need for adverse effects reporting standards in oncology clinical trials, J Clin Oncol, 22, 19, 10.1200/JCO.2004.10.911 Farnell, 2010, Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy, Radiother Oncol, 97, 136, 10.1016/j.radonc.2010.05.011 Olopade, 2005, The inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are useful to identify gastrointestinal toxicity after pelvic radiotherapy, Br J Cancer, 92, 1663, 10.1038/sj.bjc.6602552 Andreyev, 2007, Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients, Lancet Oncol, 8, 1007, 10.1016/S1470-2045(07)70341-8 Gami, 2003, How patients manage gastrointestinal symptoms after pelvic radiotherapy, Aliment Pharmacol Ther, 18, 987, 10.1046/j.1365-2036.2003.01760.x Andreyev, 2014, Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial, Lancet, 382, 2084, 10.1016/S0140-6736(13)61648-7 Taylor, 2016, Improving the Wellbeing of Men by Evaluating and Addressing the Gastrointestinal Late Effects of Radical Treatment for Prostate Cancer (EAGLE): study protocol for a mixed-method implementation project, BMJ Open, 6, 10.1136/bmjopen-2016-011773 Andreyev, 2014, Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial, Lancet, 382, 2084, 10.1016/S0140-6736(13)61648-7 Taylor, 2016, The three item ALERT-B questionnaire provides a validated screening questionnaire to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors, Clin Oncol, 28, e139, 10.1016/j.clon.2016.06.004 Rnic, 2013, Measuring symptoms in localized prostate cancer: a systematic review of assessment questionnaires, Prostate Cancer Prostatic Dis, 16, 111, 10.1038/pcan.2013.1 Justice, 1999, Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms, J Acquir Immune Defic Syndr, 21, 126 Hosseini, 2010, Sensitivity and specificity of International Prostate Symptom Score (IPSS) for the screening of Iranian patients with prostate cancer, Acta Med Iran, 49, 451 Svedlund, 1988, GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease, Dig Dis Sci, 33, 129, 10.1007/BF01535722 Revicki, 1997, Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease, Qual Life Res, 7, 75, 10.1023/A:1008841022998 Kulich, 2008, Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study, Health Qual Life Outcomes, 6, 12, 10.1186/1477-7525-6-12 Dimenäs, 1995, Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer, Scand J Gastroenterol, 30, 1046, 10.3109/00365529509101605 Wiklund, 2006, Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community, Am J Gastroenterol, 101, 18, 10.1111/j.1572-0241.2005.00343.x Iwarzon, 2009, Functional status, health-related quality of life and symptom severity in patients with chronic intestinal pseudo-obstruction and enteric dysmotility, Scand J Gastroenterol, 44, 700, 10.1080/00365520902840806 Lohiniemi, 2000, Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets, Scand J Gastroenterol, 35, 947, 10.1080/003655200750023002 Liedman, 2001, Symptom control may improve food intake, body composition, and aspects of quality of life after gastrectomy in cancer patients, Dig Dis Sci, 46, 2673, 10.1023/A:1012719211349 Namikawa, 2011, Double tract reconstruction after distal gastrectomy for gastric cancer is effective in reducing reflux esophagitis and remnant gastritis with duodenal passage preservation, Langenbeck’s Arch Surgery, 396, 769, 10.1007/s00423-011-0777-8 Russo, 2013, The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study, BMC Cancer, 13, 56, 10.1186/1471-2407-13-56 Szymanski, 2010, Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors, Urology, 76, 1245, 10.1016/j.urology.2010.01.027 Wei, 2000, Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer, Urology, 56, 899, 10.1016/S0090-4295(00)00858-X Sanda M, Wei J, Litwin M. Scoring Instructions for the Expanded Prostate cancer Index Composite Short Form (EPIC-26). Available from: https://medicine.umich.edu/dept/urology/research/epic accessed to 7th Feb. 2020. Pinkawa, 2011, Interpreting the clinical significance of quality of life score changes after radiotherapy for localized prostate cancer, Curr Urol, 5, 137, 10.1159/000327467 Skolarus, 2015, Minimally important difference for the expanded prostate cancer index composite short form, Urology, 85, 101, 10.1016/j.urology.2014.08.044